Advertise with us
Medical Group

Annals of Antivirals and Antiretrovirals

Journal Information
  • Volume/IssueClick here
  • Review ProcessDouble Blind
    • Publication lead time3 - 4 weeks
    • Indexing statusYes; Purview
    • Manuscript Processing ChargesClick here
    • Submission ChargesNo
    • Waiver policy for APCYes
    • Language of Full TextEnglish
    • Full-text formats availablePDF, HTML
  • Show +
Best Practices
  • Type of LicenseCreative Commons
  • Open AccessYes; Policy
    • Does the author retain unrestricted copyright?Yes
    • Does the author retain publishing rights?Yes
    • Permanent article identifierDOI (Digital Object Identifier)
  • Show +
Publisher Information

Editor-In-Chief

Peter Lloyd Nara
Peter Lloyd Nara

Private Compnay- Biological Mimetics, Inc., USA

Email: peter.nara@gmail.com
Tel: 301-514-4917; 301-51

Skype: peter.nara-bmi
More Info.

Editorial Board Join as Editor

Pramod Kumar
Head
Department of Dermatology G.U.M
Saham Hospital
Oman
kumarpramod5@rediffmail.com
AAA

Research Interest: Paediatric Dermatology, Contact and Occupational Dermatoses, Clinical Dermatology, Experimental Dermatology and Dermatosurgery.


More Info.
Larance Ronsard
Harvard Medical School
USA
laraphds@gmail.com
AAA

Research Interest: Identification of Immunomodulatory, Effects of a Drug in Rhesus Monkey Model, Canonical Signaling Pathways.


More Info.
A P Malyshkin
Head
Division of Laboratory Diagnosis Orenburg Regional Tuberculosis Control Center
Russia
malishkin_54@mail.ru
AAA

Research Interest: Microbiology, Immunology, Infectious Diseases and Their Prevention.



More Info.
Farsang Attila
Project Manager
Virologist
Leading of Molecular Biological Laboratory
Hungary
FarsangA@nebih.gov.hu
AAA

Research Interest: Vaccine, Vaccinology, HIV, gp41, Animal Trials



More Info.
Marina K. Kukhanova
Professor
Molecular Biology
Institute of Russian Academy of Sciences
Russia
kukhan86@hotmail.com
AAA

Research Interest: Viral replication, antiviral and anticancer drug development, mechanism of action of potential antiviral compounds, cellular metabolism and toxicity, pharmacokinetics, enzymology, kinetics.

More Info.
Parmit Singh
National Institute of Child Health and Human Development National Institutes of Health
USA
parmit.singh@nih.gov
AAA

Research Interest: HIV-1, Retrovirology, Retroviruses, Splicing, Genetics and Molecular Biology, Chromatin Biology, NGS, Bioinformatics, Geneom Analysis.


More Info.
Christophe Vanpouille
Staff Scientist
Intercellular Interactions NICHD, NIH
France
vanpouic@mail.nih.gov
AAA

Research Interest: HIV-1, Antivirals,Tissue; Ex Vivo, Pathogens.


More Info.
Xiaofei Cheng
Associated Professor
Hangzhou Normal University
PR China
conicheng_xf@126.com
AAA

Research Interest: Plant Viruses; Virus-Host Interaction; Viral Infection; Anti-Viral Research


More Info.
M Obulesu
Department of Materials Science
University of Tsukuba
Japan
mobulesu@gmail.com
AAA

Research Interest: Alzheimer's Disease, Nanoparticles, Hydrogels, Biomaterials

More Info.
Vykuntaraju K N Gowda
Assistant Professor
Pediatric Neurology Indira Gandhi Institute of Child Health
India
drknvraju@hotmail.com
AAA

Research Interest: Pediatric Epilepsy, Neuroinfections and Para Infectious Disorders, Developmental Neurology, Cerebral Palsy




More Info.
View more

Castalagin: Some aspects of the mode of Anti-Herpes Virus Activity

Published On: February 15, 2018 | Pages: 004 - 007

Author(s): N Vilhelmova-Ilieva, D Deffieux, S Quideau, AS Galabov*
Abstract View Full Article View DOI: 10.17352/aaa.000004

Thiolutin Derivatives as inhibitor of RNA-Dependent RNA Polymerase (RdRP) of Hepatitis C Virus: An In-silico Approach

Published On: January 17, 2018 | Pages: 001 - 003

Author(s): Muhammad Imran Qadir*, Asma Munawar, Syed Bilal Hussain
Abstract View Full Article View DOI: 10.17352/aaa.000003

Molecular Docking studies on possible Neuraminidase Inhibitors of Influenza Virus

Published On: October 10, 2017 | Pages: 005 - 007

Author(s): Jawaria Khan*, Ardas Masood, Asma Noor, Anam Munir and Muhammad Imran Qadir
Abstract View Full Article View DOI: 10.17352/aaa.000002

Lack of Difference between the Reduced Dose and Full-Dose of Antiretroviral Therapy in Terms of the Decrease in Immune Activation

Published On: January 28, 2017 | Pages: 001 - 004

Author(s): Nicolè S*, Cucchetto G, Lanzafame M, Rigo F, Lattuada E, Concia E and Vento S
Abstract View Full Article View DOI: 10.17352/aaa.000001